Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Tatva Chintan Pharma Chem Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	420.54	57.13	303.54	454.87	958.74
Depreciation & Amortization	368.47	267.63	253.9	94	81.33
Other Amortization	-	8.96	2.15	1.55	0.47
Loss (Gain) From Sale of Investments	-0.06	-0.75	-1.89	-	-
Other Operating Activities	145.19	-9.06	78.39	-28.6	-67.09
Change in Accounts Receivable	-215.03	-151.62	153.85	-280.75	322.99
Change in Inventory	-621.2	188.11	97.32	74.59	-979.38
Change in Accounts Payable	196.95	-131.05	112.48	-123.73	-30.63
Change in Other Net Operating Assets	20.03	17.36	-19.3	85.9	-84.13
Operating Cash Flow	314.89	246.71	980.44	277.83	202.3
Operating Cash Flow Growth	27.64%	-74.84%	252.89%	37.34%	2.72%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-1,138	-762.72	-1,285	-2,031	-891.57
Sale of Property, Plant & Equipment	3.58	1.39	1.55	0.68	0.78
Investment in Securities	-46.74	103.92	45.46	965.73	-1,123
Other Investing Activities	22.48	4.87	32.74	53.25	46.59
Investing Cash Flow	-1,158	-652.54	-1,205	-1,011	-1,967

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	785.84	257.49	-	637.4	422.85
Long-Term Debt Issued	60.4	-	-	8.29	-
Total Debt Issued	846.24	257.49	-	645.69	422.85
Short-Term Debt Repaid	-	-	-1,462	-	-
Long-Term Debt Repaid	-6.38	-32.19	-85.89	-139.26	-133.83
Total Debt Repaid	-6.38	-32.19	-1,548	-139.26	-133.83
Net Debt Issued (Repaid)	839.86	225.3	-1,548	506.43	289.02
Issuance of Common Stock	-	-	2,000	-	2,250
Common Dividends Paid	-23.39	-46.78	-46.78	-44.33	-
Other Financing Activities	-27.15	-12.86	-100.06	-84.15	-188.91
Financing Cash Flow	789.32	165.66	305.19	377.95	2,350

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	-1.89	0.87	-0.84	-0.86	-0.18
Net Cash Flow	-56.1	-239.3	79.39	-356.52	585.36

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	-822.85	-516.01	-304.71	-1,753	-689.27
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	-16.27%	-13.48%	-7.74%	-41.39%	-15.90%
Free Cash Flow Per Share	-35.18	-22.06	-13.31	-79.10	-32.06
Levered Free Cash Flow	-925.59	-526.95	-672.26	-529.3	-2,039
Unlevered Free Cash Flow	-907.77	-521.35	-633.82	-479.32	-2,012

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	26.87	8.96	61.51	79.97	43.51
Cash Income Tax Paid	76.79	44.98	85.62	92.9	184.07
Change in Working Capital	-619.25	-77.2	344.35	-243.99	-771.15

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error